UPDATE 1-Chelsea shareholder urges co to explore options

July 6 (Reuters) - Chelsea Therapeutics International Ltd's largest shareholder has urged the board to explore alternative approaches after the company's key experimental drug hit another regulatory road block, sending its shares up 43 percent.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.